tadalafil 5 mg
1.1 erectile dysfunction Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED). 1.2 benign prostatic hyperplasia Tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). 1.3 erectile dysfunction and benign prostatic hyperplasia Tadalafil tablets are indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH). 1.4 Limitation of Use If tadalafil tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see Clinical Studies ( 14.3)] .
UNYTER ENTERPRISES
TEAR YELLOW FJ2
FJ2 TEAR YELLOW
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16.1 How Supplied Tadalafil tablets, USP 2.5 mg are available for oral administration as off white to pale yellow coloured, almond shaped, biconvex, film coated tablets debossed with âFJ1â on one side and plain on other side Bottles of 30 count comes in a child-resistant package (NDC 16729-369-10) Bottles of 90 count comes in a child-resistant package (NDC 16729-369-15) Bottles of 500 count (NDC 16729-369-16) Bottles of 1000 count (NDC 16729-369-17) Carton of 30 (Blisters of 2 x 15) (NDC 16729-369-97) Tadalafil tablets, USP 5 mg are available for oral administration as light yellow coloured, almond shaped, biconvex, film coated tablets debossed with âFJ2â on one side and plain on other side Bottles of 30 count comes in a child-resistant package (NDC 16729-370-10) Bottles of 90 count comes in a child-resistant package (NDC 16729-370-15) Bottles of 500 count (NDC 16729-370-16) Bottles of 1000 count (NDC 16729-370-17) Carton of 30 (Blisters of 2 x 15) (NDC 16729-370-97) Tadalafil tablets, USP 10 mg are available for oral administration as yellow coloured, almond shaped, biconvex, film coated tablets, debossed with âFJ3â on one side and plain on other side Bottles of 30 count comes in a child-resistant package (NDC 16729-371-10) Bottles of 90 count comes in a child-resistant package (NDC 16729-371-15) Bottles of 500 count (NDC 16729-371-16) Bottles of 1000 count (NDC 16729-371-17) Tadalafil tablets, USP 20 mg are available for oral administration as yellow coloured, almond shaped, biconvex, film coated tablets, debossed with âFJ4â on one side and plain on other side Bottles of 30 count comes in a child-resistant package (NDC 16729-372-10) Bottles of 90 count comes in a child-resistant package (NDC 16729-372-15) Bottles of 500 count (NDC 16729-372-16) Bottles of 1000 count (NDC 16729-372-17)
More pills like TEAR FJ2